Fresenius Medical Care Stock Analysis

Fresenius Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 0.38. The entity last dividend was issued on the 23rd of May 2025. The firm had 2:1 split on the 4th of December 2012. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States. To learn more about Fresenius Medical Care call FACHE MBA at 49 6172 609 0 or check out https://www.freseniusmedicalcare.com.

Fresenius Medical Care Investment Alerts

Fresenius Largest EPS Surprises

View All Earnings Estimates

Fresenius Medical Environmental, Social, and Governance (ESG) Scores

Fresenius Stock Institutional Investors

Note, although Fresenius Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Fresenius Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 14.27 B.

Fresenius Profitablity

The company has Net Profit Margin of 0.04 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.1 %, which entails that for every 100 dollars of revenue, it generated $0.1 of operating income.

Management Efficiency

Fresenius Medical Care has Return on Asset of 0.0333 % which means that on every $100 spent on assets, it made $0.0333 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0632 %, implying that it generated $0.0632 on every 100 dollars invested. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.03 in 2026. Return On Capital Employed is likely to drop to 0.05 in 2026. At this time, Fresenius Medical's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 869.4 M in 2026, whereas Other Current Assets are likely to drop slightly above 711.4 M in 2026.

Technical Drivers

As of the 16th of February 2026, Fresenius Medical shows the Mean Deviation of 1.27, coefficient of variation of 2846.98, and Downside Deviation of 1.87. Fresenius Medical Care technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Fresenius Medical Care variance, as well as the relationship between the value at risk and skewness to decide if Fresenius Medical Care is priced favorably, providing market reflects its regular price of 24.44 per share. Given that Fresenius Medical has jensen alpha of 0.0064, we urge you to verify Fresenius Medical Care's prevailing market performance to make sure the company can sustain itself at a future point.

Fresenius Medical Care Price Movement Analysis

Fresenius Medical Outstanding Bonds

Fresenius Medical Predictive Daily Indicators

Fresenius Medical Corporate Filings

Fresenius Medical Forecast Models

Fresenius Medical's time-series forecasting models are one of many Fresenius Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fresenius Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Fresenius Medical Bond Ratings

Fresenius Medical Care financial ratings play a critical role in determining how much Fresenius Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Fresenius Medical's borrowing costs.

Fresenius Medical Care Debt to Cash Allocation

Fresenius Medical Care has 11 B in debt with debt to equity (D/E) ratio of 0.88, which is OK given its current industry classification. Fresenius Medical Care has a current ratio of 1.16, demonstrating that it is not liquid enough and may have problems paying out its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Fresenius to invest in growth at high rates of return.

Fresenius Medical Common Stock Shares Outstanding Over Time

Fresenius Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Fresenius Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Fresenius Medical Debt Ratio

23.0

It appears most of the Fresenius Medical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Fresenius Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Fresenius Medical, which in turn will lower the firm's financial flexibility.

Fresenius Medical Corporate Bonds Issued

Fresenius Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Fresenius Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fresenius shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Fresenius Medical. By using and applying Fresenius Stock analysis, traders can create a robust methodology for identifying Fresenius entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Fresenius analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Fresenius analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Fresenius Medical Care stock analysis indicators help investors evaluate how Fresenius Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Fresenius Medical shares will generate the highest return on investment. By understating and applying Fresenius Medical stock analysis, traders can identify Fresenius Medical position entry and exit signals to maximize returns.

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.